RPL9P33

Across TCGA pan-cancer cohorts, RPL9P33 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RPL9P33’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LUSC), where RPL9P33 RNA is repressed in tumor relative to normal tissue. In most cancer types RPL9P33 is over-expressed in tumor, although a few such as LUSC and THCA show the opposite, repressed pattern.

LUSC, THCA, and COAD are the cancer types where RPL9P33 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL9P33 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUSC	All	All	−0.103	.005	3	view →
THCA	All	All	−0.071	.005	2	view →
COAD	Female	All	−0.097	.032	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

RPL9P33–LUSC

Open the LUSC breakdown →